Cairns N - Search Results

1

Increased glyceraldehyde 3-phosphate dehydrogenase levels in the brain of patients with Down's syndrome.

Lubec G, Labudova O, Cairns N, Fountoulakis M. Lubec G, et al. Among authors: cairns n. Neurosci Lett. 1999 Jan 29;260(2):141-5. doi: 10.1016/s0304-3940(98)00952-5. Neurosci Lett. 1999. PMID: 10025719

2

Overexpressed protein disulfide isomerase in brains of patients with sporadic Creutzfeldt-Jakob disease.

Yoo BC, Krapfenbauer K, Cairns N, Belay G, Bajo M, Lubec G. Yoo BC, et al. Among authors: cairns n. Neurosci Lett. 2002 Dec 16;334(3):196-200. doi: 10.1016/s0304-3940(02)01071-6. Neurosci Lett. 2002. PMID: 12453628

3

Increased RNA levels of the 25 kDa synaptosomal associated protein in brain samples of adult patients with Down Syndrome.

Greber-Platzer S, Fleischmann C, Nussbaumer C, Cairns N, Lubec G. Greber-Platzer S, et al. Among authors: cairns n. Neurosci Lett. 2003 Jan 16;336(2):77-80. doi: 10.1016/s0304-3940(02)01150-3. Neurosci Lett. 2003. PMID: 12499044

4

Human brain cytosolic histamine-N-methyltransferase is decreased in Down syndrome and increased in Pick's disease.

Kim SH, Krapfenbauer K, Cheon MS, Fountoulakis M, Cairns NJ, Lubec G. Kim SH, et al. Neurosci Lett. 2002 Mar 22;321(3):169-72. doi: 10.1016/s0304-3940(02)00051-4. Neurosci Lett. 2002. PMID: 11880199

5

Human brain nucleoside diphosphate kinase activity is decreased in Alzheimer's disease and Down syndrome.

Kim SH, Fountoulakis M, Cairns NJ, Lubec G. Kim SH, et al. Biochem Biophys Res Commun. 2002 Aug 30;296(4):970-5. doi: 10.1016/s0006-291x(02)02035-1. Biochem Biophys Res Commun. 2002. PMID: 12200143

6

Decreased protein levels of stathmin in adult brains with Down syndrome and Alzheimer's disease.

Cheon MS, Fountoulakis M, Cairns NJ, Dierssen M, Herkner K, Lubec G. Cheon MS, et al. Among authors: cairns nj. J Neural Transm Suppl. 2001;(61):281-8. doi: 10.1007/978-3-7091-6262-0_23. J Neural Transm Suppl. 2001. PMID: 11771751

7

Increased kynurenic acid levels and decreased brain kynurenine aminotransferase I in patients with Down syndrome.

Baran H, Cairns N, Lubec B, Lubec G. Baran H, et al. Among authors: cairns n. Life Sci. 1996;58(21):1891-9. doi: 10.1016/0024-3205(96)00173-7. Life Sci. 1996. PMID: 8637415

8

Polyamines in frontal cortex of patients with Down syndrome and Alzheimer disease.

Seidl R, Beninati S, Cairns N, Singewald N, Risser D, Bavan H, Nemethova M, Lubec G. Seidl R, et al. Among authors: cairns n. Neurosci Lett. 1996 Mar 15;206(2-3):193-5. doi: 10.1016/s0304-3940(96)12451-4. Neurosci Lett. 1996. PMID: 8710184

9

Endogenous opioids in frontal cortex of patients with Down syndrome.

Risser D, You ZB, Cairns N, Herrera-Marschitz M, Seidl R, Schneider C, Terenius L, Lubec G. Risser D, et al. Among authors: cairns n. Neurosci Lett. 1996 Jan 19;203(2):111-4. doi: 10.1016/0304-3940(95)12275-3. Neurosci Lett. 1996. PMID: 8834106

10

Decreased cyclin dependent kinase in brain of patients with Down syndrome.

Bernert G, Nemethova M, Herrera-Marschitz M, Cairns N, Lubec G. Bernert G, et al. Among authors: cairns n. Neurosci Lett. 1996 Sep 20;216(1):68-70. doi: 10.1016/0304-3940(96)12988-8. Neurosci Lett. 1996. PMID: 8892394

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

780 results

Search Page

Filters